Medicine
Dasatinib 140 mg tablet
Dasatinib 140 mg tablet is a generic prescription medicine for oral use, made by 14 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Dasatinib tablets should be stored at 20°C to 25°C (68°F to 77°F), excursions…
Key facts
- Active ingredient (INN)
- Dasatinib
- Brand
- Sold under the generic name
- Strength
- 140 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 1 blister pack, 1 bottle and 14 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAurobindo PharmaIndiaZydus LifesciencesIndiaBioconIndiaDr. Reddy's LaboratoriesIndiaLupinIndiaNovadoz PharmaceuticalsIndiaApotexAvKAREBluePoint Laboratories
- Origin register
- US FDA, United States
- Storage
- Dasatinib tablets should be stored at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01EA02 Dasatinib
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 September 2024
- Identifiers
- RxCUI 643105, 643107, 643109 +3DailyMed set ID 4582bf1e-d0c4-88ec-f76c-4670bd7b14ad, f9b79d54-9bee-4c93-9c87-f3e65d91f146, 645fcf26-1b2f-40c5-881b-8effe02defbd +13NDC 82009-197, 72603-927, 46708-689 +13Application ANDA217217, ANDA216261, NDA021986 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 46708-689-30 | Alembic PharmaceuticalsIndia | 11 November 2025 |
| 30 tablet, film coated in 1 bottle | 62332-689-30 | Alembic PharmaceuticalsIndia | 11 November 2025 |
| 30 tablet in 1 bottle | 70710-1746-3 | Zydus LifesciencesIndia | 3 March 2025 |
| 30 tablet in 1 bottle | 70771-1906-3 | Zydus LifesciencesIndia | 3 March 2025 |
| 1 blister pack in 1 carton / 15 tablet in 1 blister pack | 59651-547-15 | Aurobindo PharmaIndia | 22 April 2025 |
| 30 tablet in 1 bottle | 59651-547-30 | Aurobindo PharmaIndia | 22 April 2025 |
| 30 tablet, film coated in 1 bottle | 70377-088-11 | BioconIndia | 3 March 2025 |
| 30 tablet, film coated in 1 bottle | 43598-604-30 | Dr. Reddy's LaboratoriesIndia | 3 March 2025 |
| 1 bottle in 1 carton / 30 tablet in 1 bottle | 70748-213-06 | LupinIndia | 30 January 2026 |
| 30 tablet in 1 bottle | 72205-324-30 | Novadoz PharmaceuticalsIndia | 11 September 2026 |
| 30 tablet, film coated in 1 bottle | 60505-3817-3 | Apotex | 3 September 2024 |
| 30 tablet, film coated in 1 bottle | 0480-3524-56 | Teva Pharmaceuticals | 18 September 2025 |
| 30 tablet, film coated in 1 bottle | 73190-051-30 | AvKARE | 18 November 2025 |
| 30 tablet, film coated in 1 bottle | 68001-665-04 | BluePoint Laboratories | 5 December 2025 |
| 30 tablet, film coated in 1 bottle | 72603-927-01 | NorthStar RxLLC | 1 June 2026 |
| 1 bottle in 1 carton / 30 tablet in 1 bottle | 66993-238-30 | Prasco Laboratories | 3 September 2024 |
| 30 tablet, film coated in 1 bottle | 82009-197-30 | Quallent Pharmaceuticals Health | 2 November 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Dasatinib 140 mg tablet.
Other strengths and forms of Dasatinib
Clinical summary
Dasatinib is a kinase inhibitor indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Dasatinib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DasatinibFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SPRYCEL prescribing information (ER Squibb & Sons) · U.S. National Library of Medicine, DailyMed
- Sprycel: European public assessment report (EPAR) · European Medicines Agency
- Dasatinib Accord Healthcare: European public assessment report (EPAR) · European Medicines Agency
Need Dasatinib 140 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.